(Q37425257)

20 August 2017

1 reference

title

Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions (English)

1 reference

20 August 2017

Siegfried Ansorge

1

1 reference

20 August 2017

Ute Bank

2

1 reference

20 August 2017

Anke Heimburg

3

1 reference

20 August 2017

Martin Helmuth

4

1 reference

20 August 2017

Gudrun Koch

5

1 reference

20 August 2017

Janine Tadje

6

1 reference

20 August 2017

Uwe Lendeckel

7

1 reference

20 August 2017

Carmen Wolke

8

1 reference

20 August 2017

Klaus Neubert

9

1 reference

20 August 2017

Jürgen Faust

10

1 reference

20 August 2017

Petra Fuchs

11

1 reference

20 August 2017

Dirk Reinhold

12

1 reference

20 August 2017

Anja Thielitz

13

1 reference

20 August 2017

Michael Täger

14

1 reference

20 August 2017

publication date

1 January 2009

1 reference

Clinical Chemistry and Laboratory Medicine

20 August 2017

published in

1 reference

20 August 2017

volume

47

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

253-261

1 reference

Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Dipeptidyl peptidase II (DPPII), a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Membrane bound members of the M1 family: more than aminopeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

CD13--not just a marker in leukemia typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

TH17 cells in development: an updated view of their molecular identity and genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Synergistic action of DPIV and APN in the regulation of T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Roles of TGFbeta signaling in epidermal/appendage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Wnt signaling induces epithelial differentiation during cutaneous wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Dipeptidyl peptidase 8/9-like activity in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Irreversible Inhibition of Dipeptidyl Peptidase 8 by Dipeptide-Derived Diaryl Phosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

Development of potent and selective dipeptidyl peptidase II inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.063

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.063

1 reference

20 August 2017

1 reference